Travere Therapeutics (TVTX) Accumulated Expenses (2011 - 2026)
Travere Therapeutics (TVTX) posted Accumulated Expenses of $136.27 million for Q2 2026, up 66.8% from $81.68 million a year earlier and up 30.5% from the prior quarter.
Travere Therapeutics (TVTX) Accumulated Expenses (2011 - 2026) Analysis & Trends
At the end of FY2025, Travere Therapeutics' Accumulated Expenses came in at $126.04 million, up 46.5% from FY2024.
- Annual Accumulated Expenses shows a five-year compound annual growth rate of 17.3% (FY2020 to FY2025).
- In prior years, Travere Therapeutics' Accumulated Expenses was $86.03 million in FY2024 (-27.7%), $118.99 million in FY2023 (+24.3%), $95.74 million in FY2022 (+27.4%) and $75.18 million in FY2021 (+32.4%).
- The Q2 2026 figure stands as the highest quarterly Accumulated Expenses since Q1 2024.
- On a year-over-year basis, Accumulated Expenses has increased in each of the last five quarters, with growth averaging 11.6% over the last eight quarters.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q2 2026, with growth of 66.8%; the weakest was Q1 2025, with a decline of 44.8%.
- According to Business Quant data, Accumulated Expenses for the three prior quarters was $104.41 million (Q1 2026), $126.04 million (Q4 2025) and $105.76 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Travere Therapeutics | 5.35 Bn | 4.95 Bn | 167.41 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 136.27 Mn |
| Mar 31, 2026 | 104.41 Mn |
| Dec 31, 2025 | 126.04 Mn |
| Sep 30, 2025 | 105.76 Mn |
| Jun 30, 2025 | 81.68 Mn |
| Mar 31, 2025 | 77.11 Mn |
| Dec 31, 2024 | 86.03 Mn |
| Sep 30, 2024 | 83.92 Mn |
| Jun 30, 2024 | 79.64 Mn |
| Mar 31, 2024 | 139.58 Mn |
| Dec 31, 2023 | 118.99 Mn |
| Sep 30, 2023 | 95.71 Mn |
| Jun 30, 2023 | 88.75 Mn |
| Mar 31, 2023 | 85.77 Mn |
| Dec 31, 2022 | 95.74 Mn |
| Sep 30, 2022 | 88.38 Mn |
| Jun 30, 2022 | 82.69 Mn |
| Mar 31, 2022 | 69.24 Mn |
| Dec 31, 2021 | 75.18 Mn |
| Sep 30, 2021 | 63.31 Mn |
Travere Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=TVTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();